Federal Circuit affirms PTAB decision on Purdue painkiller patents

15-06-2017

Federal Circuit affirms PTAB decision on Purdue painkiller patents

Savushkin / iStockmedia.com

The US Court of Appeals for the Federal Circuit has affirmed a decision by the Patent Trial and Appeal Board (PTAB) which found that two patent applications by Purdue Pharma were unpatentable.


US Court of Appeals for the Federal Circuit, Purdue Pharma, patent, unpatentable, Recro Technology, PTAB,

LSIPR